IDEAS home Printed from https://ideas.repec.org/a/bla/ijhplm/v34y2019i1p71-86.html
   My bibliography  Save this article

Do we know the cost of orthopaedic care?

Author

Listed:
  • Kunal Kulkarni
  • Sophie Shepherd

Abstract

Introduction The increasingly complex care needs of an expanding and ageing population leave a growing dichotomy between demand and supply. With sustainable cost‐efficiency gains paramount, this study explored awareness of trauma and orthopaedic (T&O) care costs among patients and health care providers, alongside the impact of greater cost awareness on care quality, experience, and equality. Materials and methods Surveys were distributed over a 2‐week period, at a single site, to in/outpatients and health care professionals allied to T&O. They evaluated (1) awareness of the costs of several common aspects of T&O care and (2) opinions on improved cost education. Results Most professionals and patients had limited and markedly variable awareness of costs. Expensive items (>£200) were commonly underestimated, and cheap items (≤£200) were overestimated. The majority reported greater cost awareness might influence their approach to care decisions. Discussion Cost ignorance restricts cost‐efficiency and provision of equitable care. Given the widespread lack of cost education, there is unsurprisingly a lack of cost awareness among patients and professionals alike. Cost savings through “reduced waste” were a commonly highlighted potential benefit of greater cost awareness. Patients and professionals alike must become increasingly accountable for ensuring effective and efficient use of resources.

Suggested Citation

  • Kunal Kulkarni & Sophie Shepherd, 2019. "Do we know the cost of orthopaedic care?," International Journal of Health Planning and Management, Wiley Blackwell, vol. 34(1), pages 71-86, January.
    • Handle: RePEc:bla:ijhplm:v:34:y:2019:i:1:p:71-86
    DOI: 10.1002/hpm.2571
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/hpm.2571
    Download Restriction: no
    File URL: https://libkey.io/10.1002/hpm.2571?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. G Michael Allan & Joel Lexchin & Natasha Wiebe, 2007. "Physician Awareness of Drug Cost: A Systematic Review," PLOS Medicine, Public Library of Science, vol. 4(9), pages 1-11, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. G Michael Allan & Christina Korownyk & Kate LaSalle & Ben Vandermeer & Victoria Ma & Douglas Klein & Donna Manca, 2010. "Do Randomized Controlled Trials Discuss Healthcare Costs?," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-5, August.
    2. Gauri Billa & Karan Thakkar & Sarita Jaiswar & Dinesh Dhodi, 2014. "A Cross-Sectional Study to Evaluate the Awareness and Attitudes of Physicians Towards Reducing the Cost of Prescription Drugs, Mumbai," Applied Health Economics and Health Policy, Springer, vol. 12(2), pages 125-137, April.
    3. Barkowski, Scott, 2021. "Physician Response to Prices of Other Physicians: Evidence from a Field Experiment," MPRA Paper 108966, University Library of Munich, Germany.
    4. Stefanie Heinzle, 2012. "Disclosure of Energy Operating Cost Information: A Silver Bullet for Overcoming the Energy-Efficiency Gap?," Journal of Consumer Policy, Springer, vol. 35(1), pages 43-64, March.
    5. Lexchin, Joel, 2009. "Pricing of multiple dosage prescription medications: An analysis of the Ontario Drug Benefit Formulary," Health Policy, Elsevier, vol. 91(2), pages 142-147, July.
    6. Ida Iren Eriksen & Hans Olav Melberg & Berit Bringedal, 2013. "Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey," PLOS ONE, Public Library of Science, vol. 8(9), pages 1-1, September.
    7. Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
    8. Timothée Lehut & Céline Lambert & Romain Mortier & Emmanuel Futier & Russell Chabanne & Ulrich Bauer & Philippe Verdier & Ramin Ravan & Philippe Ocquidant & Charline Mourgues & Alexandre Lautrette, 2024. "Cost awareness among intensivists in their daily clinical practice: a prospective multicentre study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(9), pages 1529-1537, December.
    9. D. Ackerly & Seth Glickman & Kevin Schulman, 2010. "Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs," PharmacoEconomics, Springer, vol. 28(5), pages 429-438, May.
    10. Mousnad, Mohamed Awad & Shafie, Asrul Akmal & Ibrahim, Mohamed Izham, 2014. "Systematic review of factors affecting pharmaceutical expenditures," Health Policy, Elsevier, vol. 116(2), pages 137-146.
    11. Fraeyman, Jessica & Symons, Linda & De Loof, Hans & De Meyer, Guido R.Y. & Remmen, Roy & Beutels, Philippe & Van Hal, Guido, 2015. "Medicine price awareness in chronic patients in Belgium," Health Policy, Elsevier, vol. 119(2), pages 217-223.
    12. Luca Iaboli & Luana Caselli & Angelina Filice & Gianpaolo Russi & Eleonora Belletti, 2010. "The Unbearable Lightness of Health Science Reporting: A Week Examining Italian Print Media," PLOS ONE, Public Library of Science, vol. 5(3), pages 1-6, March.
    13. Cedric Thomas Silveira, 2023. "Decoding a Doctor’s Prescription: A Study," Jindal Journal of Business Research, , vol. 12(1), pages 73-84, June.
    14. Mee-Lang Cheoun & Jongho Heo & Woong-Han Kim, 2021. "Antimicrobial Resistance: KAP of Healthcare Professionals at a Tertiary-Level Hospital in Nepal," IJERPH, MDPI, vol. 18(19), pages 1-13, September.
    15. Rodríguez-Calvillo, Javier A. & Lana, Alberto & Cueto, Antonio & Markham, Wolfgang A. & López, Maria Luisa, 2011. "Psychosocial factors associated with the prescription of generic drugs," Health Policy, Elsevier, vol. 101(2), pages 178-184, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:ijhplm:v:34:y:2019:i:1:p:71-86. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0749-6753 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.